Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.
Since Nov 19, 2025
Transactions
15
Purchases
0
Sales
15
Purchase value
$0.00
Sale value
$4.77M
Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.
Chris DegnanChief Financial Officer
4
Filed Oct 9, 2026Period of report Oct 8, 20260001437749-26-032421
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleOct 8, 2026
Ordinary SharesF2
2,202
$36.69
$80.79K
4,561
Direct
Filing footnotes · 3
F1Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
F2Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
F3The reporting person was granted RSUs on October 8, 2024 representing 13,450 ordinary shares. The RSUs will vest in three equal annual installments from October 8, 2025.
Filed Sep 9, 2026Period of report Sep 7, 20260001437749-26-029965
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleSep 8, 2026
Ordinary SharesF2
871
$42.92
$37.38K
59,882
Direct
Jason Drew SmithGeneral Counsel
4
Filed Sep 9, 2026Period of report Sep 7, 20260001437749-26-029963
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleSep 8, 2026
Ordinary SharesF2
1,519
$42.54
$64.62K
53,141
Direct
Mark SchoenbergChief Medical Officer
4
Filed Aug 24, 2026Period of report Aug 20, 20260001437749-26-028840
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 20, 2026
ordinary sharesF1
60,677
$47.05
$2.85M
59,086
Direct
Mark SchoenbergChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Jul 10, 2026Period of report Jul 9, 20260001437749-26-023290
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Mark SchoenbergChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Jun 24, 2026Period of report Jun 22, 20260001437749-26-021523
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Mark SchoenbergChief Medical Officer
4
Filed Jun 9, 2026Period of report Jun 8, 20260001437749-26-019964
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJun 8, 2026
Ordinary SharesF2
5,222
$27.30
$142.56K
139,763
Direct
Mark SchoenbergChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed May 11, 2026Period of report May 8, 20260001437749-26-016104
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Jason Drew SmithGeneral Counsel
4
Filed Feb 11, 2026Period of report Jan 31, 20260001437749-26-003778
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 3, 2026
Ordinary SharesF2
2,654
$19.69
$52.26K
52,934
Direct
Mark SchoenbergChief Medical Officer
4
Filed Feb 4, 2026Period of report Feb 3, 20260001437749-26-003040
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 3, 2026
Ordinary SharesF1
1,844
$19.69
$36.31K
150,514
Direct
Mark SchoenbergChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Nov 20, 2025Period of report Nov 19, 20250001437749-25-035821
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.
Filing footnotes · 3
F1Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
F2Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
F3The reporting person was granted RSUs on September 7, 2023 representing 5,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024.
F1Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
F2Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
F3The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024.
F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.30 to $49.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F1Transaction made pursuant to a duly adopted trading plan under Rule 10b5-1(c). The adoption date of the referenced Rule 10b5-1(c) plan is August 15, 2025. This transaction represents the final sale under such trading plan.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 and $40.02. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F1Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). Adoption date of referenced 10b5-1(c) plan is: 08-15-2025.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 and $35.08. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F1Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
F2Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
F3The reporting person was granted RSUs on June 8, 2023 representing 30,000 ordinary shares. The RSUs will vest in three equal annual installments from June 8, 2024.
F1Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). Adoption date of referenced 10b5-1(c) plan is: 08-15-2025.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 and $30.05. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F1Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
F2Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
F3The reporting person was granted RSUs on January 31, 2025 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2026.
F4The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024.
F5The reporting person was granted RSUs on January 31, 2024 representing 16,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025.
F61/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029.
F1Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). Adoption date of referenced 10b5-1(c) plan is: 08-15-2025.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 and $25.02. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.